NCT02659787View on ClinicalTrials.gov

Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Depression
Interventions
DRUG

0.2mg Buprenorphine

Sublingual buprenorphine tablets (0.2mg)

DRUG

Placebo

Placebo

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT02659787 - Effects of Buprenorphine on Mood in Adults With a Range of Depressive Symptomatology | Biotech Hunter | Biotech Hunter